Private Partnerships for Public Benefit
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
University of California San Francisco
Give to UCSFNobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
A new online project led by researchers at UCSF promises to dramatically cut the time and cost of conducting clinical trials for brain diseases, while also helping scientists analyze and track the brain functions of thousands of volunteers over time.
The ALS Treatment and Research Center, a clinical practice of the Department of Neurology at UCSF and an ALS Association-certified Center of Excellence, is expanding its support for the community of people facing amyotrophic lateral sclerosis.
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UCSF.
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
New research by UC San Francisco neuroscientists suggests that the body may get help in fast-changing situations from a specialized brain circuit that causes visual system neurons to fire more strongly during locomotion.
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
The UC San Francisco Department of Radiology and Biomedical Imaging recently won a very competitive grant for traumatic brain injury research. Out of 400 submissions, only 16 proposals received funding.
The Clinical and Translational Science Institute at UCSF has entered into a three-year collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, marking its first industry partnership for CTSI’s Catalyst Awards program’s therapeutic track.
A new study led by researchers from UCSF Benioff Children’s Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy.
UCSF researchers are reporting a detailed account of how speech sounds are identified by the human brain. The finding offers unprecedented insight into the basis of human language and may shed light on language disorders, including dyslexia.
Joseph DeRisi, PhD, and Allison Doupe, MD, PhD were honored by the National Academy of Sciences for their “extraordinary scientific achievements” yesterday. They join 13 others in the fields of physical, biological and social sciences.
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.